At some point in collaborations formal arrangements – in whatever form – will become relevant. Please involve IXA at the earliest stage possible to assist you with this. The IXA legal counsels have extensive experience in drafting and negotiating contracts. Do you have a request from industry regarding the use of your research results? At IXA we are committed to negotiating a fair deal.
In many cases, the COVID-19 crisis has an impact on current research contracts with cooperation partners and grant providers. For more information about force majeure due to COVID-19 please look at this page.
Please do not hesitate to contact our legal department if you need advice in matters such as:
This collaboration is part of 2-year UK government-funded project to bring RxSelexTM closer to patients Amsterdam UMC and AlphaBiomics Ltd., a United Kingdom (UK)-based precision medicine company, have initiated a collaboration to personalize care in patients suffering from inflammatory bowel disease (IBD). IBD patient response to biologics therapy is highly variable, with some patients receiving long-term benefits, […]News
Fitsurance and how they ‘pivot’ during COVID-19, as a VU ‘personal health’ startup All was lost (well, almost) After a great pilot-project in Zeeland, where we measured runners on the beach, to see what a 3-day running event did with runners’ health, we stepped up our efforts to prepare for 2020, in order to make […]News
Haermonics, een spin-off van Amsterdam UMC, heeft de effectiviteit en veiligheid bewezen van het spoelen van het hartzakje na een openhartoperatie. Een experimentele opstelling zorgde voor significant minder bloedingsgerelateerde complicaties. BOM Brabant Ventures en GAP Technologies investeren in het bedrijf voor de verdere ontwikkeling van de apparatuur en de disposables. Haermonics blijft samenwerken met Amsterdam […]News